Nobuyuki Yamashita

Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials

Stephen A. Harrison, Vincent Wai‐Sun Wong, Takeshi Okanoue et al. · Journal of Hepatology · 2020 · 466 citations

Medicine, Internal Medicine, Pharmacotherapy +12

Factors contributing to ribavirin‐induced anemia

Hideyuki Nomura, Hironori Tanimoto, Eiji Kajiwara et al. · Journal of Gastroenterology and Hepatology · 2004 · 81 citations

Pharmacy, Pharmacology, Pharmacotherapy +15

Autotaxin expression is enhanced in frontal cortex of Alzheimer-type dementia patients

Ken Umemura, Nobuyuki Yamashita, Xiao-Nian Yu et al. · Neuroscience Letters · 2006 · 67 citations

Life Sciences, Neurobiology, Neuroscience +13

Switching to tenofovir alafenamide for nucleos(t)ide analogue‐experienced patients with chronic hepatitis B: week 144 results from a real‐world, multi‐centre cohort study

Eiichi Ogawa, Makoto Nakamuta, Toshimasa Koyanagi et al. · Alimentary Pharmacology & Therapeutics · 2022 · 52 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Fluvoxamine, a selective serotonin reuptake inhibitor, and 5-HT2C receptor inactivation induce appetite-suppressing effects in mice via 5-HT1B receptors

Katsunori Nonogaki, Kana Nozue, Yukiko Takahashi et al. · The International Journal of Neuropsychopharmacology · 2006 · 38 citations · Full text

Medicine, Neuroscience, Pharmacology +16